BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.3544
-0.0520 (-12.80%)
At close: Jun 2, 2026, 4:00 PM EDT
0.3522
-0.0022 (-0.62%)
Pre-market: Jun 3, 2026, 7:22 AM EDT
BioRestorative Therapies Employees
As of December 31, 2025, BioRestorative Therapies had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees increased by 3 or 27.27% compared to the previous year.
Employees
14
Change (1Y)
3
Growth (1Y)
27.27%
Revenue / Employee
$25,562
Profits / Employee
-$789,756
Market Cap
9.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 3 | 27.27% | 13 | 1 |
| Dec 31, 2024 | 11 | 0 | - | 11 | 0 |
| Dec 31, 2023 | 11 | 1 | 10.00% | 11 | 0 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2021 | 7 | 2 | 40.00% | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| BiomX | 20 |
| Imunon | 20 |
| NuCana | 12 |
| Aprea Therapeutics | 8 |
| Ernexa Therapeutics | 7 |
| Creative Medical Technology Holdings | 4 |
| Addex Therapeutics | 2 |
BRTX News
- 6 days ago - BioRestorative Therapies shareholder Kaos Capital acquires 4.9% stake - TheFly
- 6 days ago - Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - PRNewsWire
- 7 days ago - BioRestorative Therapies completes Phase 2 dosing of BRTX-100 - TheFly
- 7 days ago - BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data - GlobeNewsWire
- 19 days ago - BioRestorative Therapies Quarterly report: Q1 2026 - Filings
- 20 days ago - BioRestorative Therapies presents preclinical data on MSC exosome proteomics - TheFly
- 20 days ago - BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals - GlobeNewsWire
- 26 days ago - BioRestorative Therapies reports expanded Phase 2 blinded dataset for BRTX-100 - TheFly